Meinian OneHealth and Alibaba’s Damo Academy have partnered to bring AI screening to health exams, targeting early detection of cancer and chronic diseases. The CT-based model, recently designated a breakthrough device by the FDA, has reportedly shown high accuracy in identifying pancreatic and gastrointestinal cancers and will now be piloted in routine checkups.